
UNITED STATES DEPARTMENT OF JUSTICE
FEDERAL PROSECUTION CASE SUMMARY & JUDICIAL DECREE
CASE ENTRY ID: DOJ-MED-2026-6610
TARGET DEFENDANT: Jaxson “Bio-Core” Vance (Age: 41)
ISSUING AUTHORITY: Office of the United States Attorney
CASE BACKGROUND & PROSECUTION FACTS
The defendant, Jaxson Vance, chief executive officer of a synthetic medical diagnostic firm, was prosecuted for executing a $68 million bio-tech investment fraud scheme. A joint investigation by the Food and Drug Administration (FDA-OCI), the Securities and Exchange Commission (SEC), and the FBI revealed that Vance claimed his company developed a revolutionary handheld genetic testing device. In reality, the device was completely non-functional, and patient diagnostic test results were manually fabricated using random computer algorithms, endangering thousands of patients who relied on accurate medical readings.
STATUTORY CONVICTIONS & APPLICABLE FEDERAL LAW
Federal prosecutors secured guilty verdicts on all counts under the following United States Codes:
-
Major Healthcare and Wire Fraud: Pursuant to 18 U.S.C. § 1343 and 18 U.S.C. § 1347.
-
Adulteration and Misbranding of Medical Devices: Pursuant to 21 U.S.C. § 331.
-
Securities Fraud Against Public Investors: Pursuant to 18 U.S.C. § 1348.
JUDICIAL EVALUATION & COURTROOM DISRUPTION
During sentencing arguments, the presiding judge highlighted that Vance deliberately introduced non-functional medical devices into clinical trials, placing patient health at grave risk purely to raise venture capital funding. Upon the formal pronouncement of his 27-year prison term, the defendant lost his temper, slamming his fists onto the defense counsel table before courtroom marshals restrained him and placed him in heavy wrist cuffs.
JUDICIAL DECREE & FINAL SENTENCING ORDERS
-
TERM OF IMPRISONMENT: Sentenced to 27 years in a federal penitentiary without eligibility for early parole.
-
FINANCIAL REMEDY: Mandatory restitution of $68,000,000 to victimized investors and medical facilities, plus full forfeiture of company patents and real estate.
-
CUSTODIAL ENFORCEMENT: Directed marshals to immediately remand the convict to the Federal Bureau of Prisons.
